Diseases & Disorders
(G12)
IRS Verified
DX Registered
990 on File
CURE RARE DISEASE INC
Financial strength (30%)
77/100
Reliability (20%)
45/100
Effectiveness (25%)
81/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$4.4M
Total Revenue
$2.0M
Total Expenses
$3.5M
Net Assets
5
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
87.6%
Fundraising Efficiency
46.5%
Operating Reserve
20.70x
Liability-to-Asset
42.2%
Revenue Diversification
99.1%
Executive Compensation
$236K
Compared with Peers
FY 2024
Compared with 638 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
87.6% | 82.3% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
7.1% | 11.5% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
5.3% | 2.8% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
46.5% | 110.9% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
20.7 mo | 11.4 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
42.2% | 12.7% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.1% | 91.5% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
92.9% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
2.3% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
54.9% | 2.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $4.4M | $2.0M | $3.5M | 87.6% | 5 |
| 2023 | $2.3M | $2.0M | $1.0M | 91.0% | 5 |
| 2022 | $2.8M | $3.2M | $627K | 91.2% | 7 |
| 2021 | $4.4M | $2.3M | N/A | — | 5 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.